Skip to content
Screener

Thermo Fisher Scientific TMO Analytical Instruments — Restructuring and other costs

Other segment segments

Laboratory Products and Biopharma Services
$33M
Life Sciences Solutions
$9M

Similar metrics at other companies

Oracle logo
ORCLCloud And License Business — Restructuring Reserve Accrual Adjustment1
-$2M-200%
Oracle logo
ORCLHardware Business — Restructuring Reserve Accrual Adjustment1
-$2M
Oracle logo
ORCLServices Business — Restructuring Reserve Accrual Adjustment1
-$11M
Hillman Solutions Corp. logo
HLMNRestructuring and other costs
$1.01M+36.3%
Clear Channel Outdoor Holdings, Inc. logo
CCORestructuring and other costs
$95K
MSC Industrial Direct Co. logo
MSMReportable Segment — Restructuring and other costs
$0-100%

Other financials

Income statement

See full
Revenue$12.0B
Operating income$2.1B
Net income$1.7B+7.4%
EPS (diluted)$4.68+9.3%

Balance sheet

See full
Cash & equivalents$4.1B-11.7%
Total debt$39.2B+4.6%
Total equity$52.7B+4.3%
Total assets$113.17B+11.8%

Cash flow

See full
Operating cash flow$2.1B+51.9%
CapEx-$1.2B-509%
Free cash flow$923.0M-16.5%

Valuation

See full
Market cap$214.46B+26.5%
Enterprise value$249.58B+23.3%
P/E30.8×+5.0×
P/S4.8×-0.9×

Profitability

See full
Gross margin58.3%
Operating margin17.2%+0.8pp
Net margin15.2%+1.0pp
FCF margin15.7%-2.1pp

Returns & leverage

See full
Return on equity13.5%+0.1pp
Debt / equity0.7×0.0×
Current ratio1.6×-0.4×

Where this comes from

Reported directly by Thermo Fisher Scientific in its filing.

Tagged under the XBRL concept tmo:RestructuringAndOtherCostsIncomeNet.

The source filing: Thermo Fisher Scientific’s 10-Q, filed May 1, 2026.

Filed
May 1, 2026, 11:00 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000097745-26-000092
(In millions)Three months ended / March 28, 2026Three months ended / March 28, 2026
Life Sciences Solutions$$9
Analytical Instruments4
Laboratory Products and Biopharma Services33
Corporate3
$$49

Item 1. Financial Statements (Unaudited)

FAQ

What is Thermo Fisher Scientific's analytical instruments — restructuring and other costs?
Thermo Fisher Scientific (TMO) reported analytical instruments — restructuring and other costs of $4M in Q1 2026.
What is the long-term trend for Thermo Fisher Scientific's analytical instruments — restructuring and other costs?
Over 2 years (2021 to 2024), Thermo Fisher Scientific's analytical instruments — restructuring and other costs has grown at a -18.4% compound annual growth rate (CAGR), from $6M to $4M.
What does analytical instruments — restructuring and other costs mean?
Costs incurred to reorganize, consolidate, or streamline the operations of the Analytical Instruments segment. These are typically non-recurring expenses related to facility closures, workforce reductions, or integration of acquired entities.

Ask your AI about Thermo Fisher Scientific's analytical instruments — restructuring and other costs.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude